"
 
Perhimpunan Dokter Paru Indonesia - Impact of Diabetes Mellitus on Drug-Resistant Tuberculosis Treatment Outcomes in Georgia
 
Link
Free Web Counters
Members
News
Mitra Kerja
Video
Tutorial Aplikasi ISR
Uploaded on May 11, 2015
World Asthma Day 2018
Uploaded on Apr 30, 2018
"
 

 

Impact of Diabetes Mellitus on Drug-Resistant Tuberculosis Treatment Outcomes in Georgia

Background. Diabetes mellitus (DM) is associated with an increased risk of tuberculosis (TB). There is growing evidence that this comorbidity might affect TB-disease presentation and treatment response.

Aims and objectives. We investigated the level of impact of diabetes mellitus on drug-resistant tuberculosis (DR-TB) treatment outcomes in condition of adequate management of both diseases.

Methods. Cohort study was provided among 1154 drug-resistant tuberculosis patients integrated in DOTS+ programme in 2009-2010 years in Georgia. Every patient was routinely investigated for DM. To compare the treatment outcomes of patients with and those without diabetes comorbidity dispersive analysis using Kruskal-Wallis - H criteria was provided.


Read More : Pulmonary tuberculosis in children from family contacts


Results.
Among 1154 DR-TB patients only 69 (5, 98%) had diabetes mellitus. All of them developed pulmonary form of TB and were HIV-negative. 61 (88, 4%) patient was male, mean age was 46, 8 (Standard deviation-12,67), mean BMI-23,44 (St.dev.- 3,78). In 3 (4,3%) patient was revealed extensively-DR-TB, in 58 (84,1%) - multi-DR-TB, and in 7 (10, 1%) - poly-DR-TB. 91,3% patients had II type of DM and 86,9% received insulin therapy. Definition: “successful treatment” received 55% diabetic patient vs 56 % non-diabetic, “Default”-36,2% vs 27,6%; “Failure” – 5,8 % vs 4,7 %; “Death” – 4,3% vs 9,6 % (p>0,05).

Conclusions. We found no significant difference in proportion of successful treatment outcomes, though default rate was rather higher in patients with diabetes than non-diabetes in the setting of adequate treatment options and management in Georgia.

 

Marina Kikvidze1 and Lali Mikiashvili1
1MDR-TB Department, National Center for Tuberculosis and Lung Diseases (NCTBLD), Tbilisi, Georgia

Sumber : http://erj.ersjournals.com/content/42/Suppl_57/P2826



PDPI Sumatera Utara. 07/05/18.




Halaman Siap Cetak  Halaman Siap Cetak

Kirimkan Pada Rekan  Kirimkan Pada Rekan